13F · 10X Genomics Inc

TXG institutional ownership and 13F activity

Track TXG institutional ownership through SEC 13F filings, including top shareholders, reported positions, portfolio weights, buys, sells, and quarterly holding trends.

Historical filing data, not live positions.Snapshot generated Sep 12, 2026 from SEC EDGAR 13F-HR information tables. 13F reports can arrive up to 45 days after quarter-end and omit many asset types.
01

TXG Institutional Ownership Snapshot

See how many institutions reported TXG, their combined market value, ownership concentration, and latest position changes.

Active holders2
Reported value$383.5M
Top 5 concentration100.0%
New holders1
Reduced holders1
Exited holders0
02

TXG Ownership Takeaways

Highlights from the latest TXG 13F filings, including the largest holder, biggest increase, largest reduction, and ownership concentration.

Largest reported holderARK Invest$383.5M · 2.49% of its portfolio
Largest increaseBased on reported share-count change versus the prior filing.
Largest reductionARK InvestReported changes can reflect trading, prices, or filing coverage.
Ownership concentration100.0%of aggregate reported value is held by the top five tracked holders.
03

Who Owns TXG? Institutional Holders

Compare 2 current and exited TXG positions by manager, shares, reported market value, portfolio weight, and quarter-over-quarter change.

ManagerSharesReported valuePortfolio weightShare changeStatus
Cathie Wood / ARK InvestJun 30, 2026 · CIK 000169774810M$383.5M2.49%-14.6%Reduced
Stanley Druckenmiller / Duquesne Family OfficeJun 30, 2026 · CIK 0001536411403,100$15,4550.30%NewNew
04

TXG Institutional Buying and Selling

See which institutions opened, increased, reduced, or exited TXG positions compared with their previous 13F filing.

Increased 0

No holders in this category.

Exited 0

No holders in this category.

05

Types of Institutional Holders

Compare concentrated funds, diversified managers, and broad portfolios that reported TXG. Categories are based on portfolio breadth, not SEC classifications.

Diversified institutions1
tracked holders
Broad portfolios1
tracked holders
06

TXG Institutional Ownership by Quarter

Follow reported TXG holders, shares, and market value across recent quarters. The institutions included may vary by filing period.

Q2 20262 holders
$383.5M10.4M shares
Q1 20261 holders
$248.8M11.7M shares
Q4 20251 holders
$206.6M12.7M shares
Q3 20251 holders
$139M11.9M shares
Q2 20251 holders
$160.9M13.9M shares
QuarterHoldersReported valueSharesNewExits
Jun 30, 20262$383.5M10.4M10
Mar 31, 20261$248.8M11.7M00
Dec 31, 20251$206.6M12.7M00
Sep 30, 20251$139M11.9M00
Jun 30, 20251$160.9M13.9M00
07

Stocks Held by Similar Institutions

Discover other stocks reported by institutions that also hold TXG, and compare holder counts, market value, and concentration.

08

Common Questions About TXG

Who is the largest tracked institutional holder of TXG?

ARK Invest is the largest active holder in the current TXG sample, reporting $383.5M. The TXG holder table ranks every matched manager.

Which institution increased its TXG position the most?

Duquesne Family Office recorded the largest increase or new position by current reported value at $15,455. Its row appears in the TXG change section.

Which institution reduced or exited TXG most significantly?

ARK Invest recorded the largest reduction or exit by prior reported value at $248.8M.

Did new holders enter or existing holders exit TXG?

1 new holder entered and 0 holders fully exited in the current filing cycle. Counts reflect the SEC 13F filings currently included on BasisPilot.

How concentrated is tracked ownership in TXG?

The five largest tracked holders account for 100.0% of aggregate reported TXG value. This is concentration within the tracked sample, not the entire market.

How has tracked ownership in TXG changed across four quarters?

From the oldest comparable quarter to the latest, aggregate reported TXG value among tracked managers increased by 138.4%. Manager coverage can vary by quarter.

What company evidence should be checked alongside TXG's 13F changes?

Review 10X Genomics Inc's latest earnings, SEC filings, guidance, capital allocation, and material company events. Delayed 13F data alone cannot confirm that a manager still holds the same position today.

09

Sources and Methodology

Source: SEC EDGAR Form 13F-HR information tables. Positions are grouped by investment manager and ticker, then compared with the prior available filing. 13F data is delayed, historical, and does not represent a manager's complete or current portfolio.